The companies said the COVID-19 vaccine generated levels of antibodies that were similar to those of younger adults, meeting the study’s measurements of success.
Coronavirus
Wall Street Journal: Pfizer, BioNTech say vaccine is safe for young children
A syringe is filled with a first dose of the Pfizer COVID-19 vaccine at a mobile vaccination clinic during a back to school event offering school supplies, COVID-19 vaccinations, face masks, and other resources for children and their families at the Weingart East Los Angeles YMCA in Los Angeles, California on August 7, 2021.